loxapine has been researched along with Asthma, Bronchial in 1 studies
Loxapine: An antipsychotic agent used in SCHIZOPHRENIA.
Excerpt | Relevance | Reference |
---|---|---|
"In subjects with either asthma or COPD, FEV(1) decline and bronchospasm can occur following inhaled loxapine, but more frequently in asthmatic subjects." | 9.19 | Safety and tolerability of inhaled loxapine in subjects with asthma and chronic obstructive pulmonary disease--two randomized controlled trials. ( Cassella, JV; Fishman, RS; Greos, LS; Gross, N; Meltzer, EO; Spangenthal, S; Spyker, DA, 2014) |
"In subjects with either asthma or COPD, FEV(1) decline and bronchospasm can occur following inhaled loxapine, but more frequently in asthmatic subjects." | 5.19 | Safety and tolerability of inhaled loxapine in subjects with asthma and chronic obstructive pulmonary disease--two randomized controlled trials. ( Cassella, JV; Fishman, RS; Greos, LS; Gross, N; Meltzer, EO; Spangenthal, S; Spyker, DA, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gross, N | 1 |
Greos, LS | 1 |
Meltzer, EO | 1 |
Spangenthal, S | 1 |
Fishman, RS | 1 |
Spyker, DA | 1 |
Cassella, JV | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Pulmonary Safety of Staccato® Loxapine for Inhalation in Subjects With Chronic Obstructive Pulmonary Disease[NCT00889837] | Phase 1 | 53 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
Pulmonary Safety of Staccato® Loxapine for Inhalation in Subjects With Asthma[NCT00890175] | Phase 1 | 52 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for loxapine and Asthma, Bronchial
Article | Year |
---|---|
Safety and tolerability of inhaled loxapine in subjects with asthma and chronic obstructive pulmonary disease--two randomized controlled trials.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosols; Aged; Albuterol; Antipsychotic Agents; Asth | 2014 |
Safety and tolerability of inhaled loxapine in subjects with asthma and chronic obstructive pulmonary disease--two randomized controlled trials.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosols; Aged; Albuterol; Antipsychotic Agents; Asth | 2014 |
Safety and tolerability of inhaled loxapine in subjects with asthma and chronic obstructive pulmonary disease--two randomized controlled trials.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosols; Aged; Albuterol; Antipsychotic Agents; Asth | 2014 |
Safety and tolerability of inhaled loxapine in subjects with asthma and chronic obstructive pulmonary disease--two randomized controlled trials.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosols; Aged; Albuterol; Antipsychotic Agents; Asth | 2014 |